2 results
Approved WMOCompleted
The primary objectives of the study are to evaluate the safety and performance of the Horizon* AAA Stent Graft System.
Approved WMORecruiting
Phase 1: • To determine the MTD/RP2D regimen of brigatinib monotherapy when administered in pediatric and AYA patients with ALK+ ALCL or ALK+ solid tumors, including ALK+ IMT.• To characterize the PK of brigatinib administered as monotherapy in…